SPY295.44+0.56 0.19%
DIA244.88-0.14 -0.06%
IXIC9,324.59+39.71 0.43%

Catabasis Pharmaceuticals Q1 EPS $(0.500) Misses $(0.410) Estimate

Catabasis Pharmaceuticals (NASDAQ:CATB) reported quarterly losses of $(0.500) per share which missed the analyst consensus estimate of $(0.410) by 21.95 percent. This is a 19.35 percent increase over losses of $(0.620)

Benzinga · 05/12/2020 20:14

Catabasis Pharmaceuticals (NASDAQ:CATB) reported quarterly losses of $(0.500) per share which missed the analyst consensus estimate of $(0.410) by 21.95 percent. This is a 19.35 percent increase over losses of $(0.620) per share from the same period last year.